Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Therapy Based on Immune Microenvironment by Transcriptome Sequencing of Osteosarcoma, a Prospective, Multi-cohort Exploratory Clinical Study

NCT06776198 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT06776198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06776198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Therapy Based on Immune Microenvironment by Transcriptome Sequencing of Osteosarcoma, a Prospective, Multi-cohort Exploratory Clinical Study
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
March 1, 2025
Completion date
June 1, 2027
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

osteosarcoma, precision medicine, transcriptome, tumor microenvironment